Indication
Transient cerebral ischemia
Transient cerebral ischemia, commonly referred to as a transient ischemic attack (TIA), is a brief episode of temporary neurological dysfunction affecting the central nervous system, particularly the brain, due to acute, focal hypoperfusion. Read more about Transient cerebral ischemia
69 drugs 48 manufacturers
Drugs that treat it
Common Transient cerebral ischemia therapies.
ASPIRIN
ASPIRIN
ASPIRIN
ASPIRIN
ASPIRIN
ASPIRIN
ASPIRIN
ASPIRIN
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonTransient cerebral ischemia, commonly referred to as a transient ischemic attack (TIA), is a brief episode of temporary neurological dysfunction affecting the central nervous system, particularly the brain, due to acute, focal hypoperfusion.
Pathophysiologically, it occurs when localized cerebral blood flow is abruptly interrupted by thromboembolism or arterial stenosis without causing persistent cellular death or acute tissue infarction.
It is most frequently encountered in adults with underlying vascular risk factors, including hypertension, atherosclerosis, and atrial fibrillation.
Clinically, the condition is defined by the sudden onset of focal neurological deficits—such as unilateral weakness, sensory loss, visual disturbances, or dysphasia—that fully resolve, serving as a critical warning state for impending ischemic stroke.
- nih.gov
Transient cerebral ischemia, commonly referred to as a transient ischemic attack (TIA), is a brief episode of temporary neurological dysfunction affecting the central nervous system, particularly the brain, due to acute, focal hypoperfusion
- nih.gov
Transient cerebral ischemia, commonly referred to as a transient ischemic attack (TIA), is a brief episode of temporary neurological dysfunction affecting the central nervous system, particularly the brain, due to acute, focal hypoperfusion Pathophysiologically, it occurs when localized cerebral blood flow is abruptly interrupted by thromboembolism or arterial stenosis without causing persistent cellular death or acute tissue infarction
- nih.gov
Pathophysiologically, it occurs when localized cerebral blood flow is abruptly interrupted by thromboembolism or arterial stenosis without causing persistent cellular death or acute tissue infarction It is most frequently encountered in adults with underlying vascular risk factors, including hypertension, atherosclerosis, and atrial fibrillation
- heart.org
Pathophysiologically, it occurs when localized cerebral blood flow is abruptly interrupted by thromboembolism or arterial stenosis without causing persistent cellular death or acute tissue infarction
- nih.gov
It is most frequently encountered in adults with underlying vascular risk factors, including hypertension, atherosclerosis, and atrial fibrillation
- nih.gov
Clinically, the condition is defined by the sudden onset of focal neurological deficits—such as unilateral weakness, sensory loss, visual disturbances, or dysphasia—that fully resolve, serving as a critical warning state for impending ischemic stroke
Personalize your experience
Follow Transient cerebral ischemia and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.